André Goy
Impact in
- Pathology and Forensic Medicine top 0.05%
- Lymphoma Diagnosis and Treatment
- Genetics top 0.1%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 208
- Genetics 132
- Chronic Lymphocytic Leukemia Research 124
- Co-authors
- Barbara Pro (42 shared papers)K. Stephen Suh (24 shared papers)Peter McLaughlin (40 shared papers)Jorge Romaguera (38 shared papers)Luis Fayad (40 shared papers)Anas Younes (32 shared papers)Owen A. O’Connor (19 shared papers)Brad S. Kahl (21 shared papers)
- Journals
- Blood (122 papers)Journal of Clinical Oncology (55 papers)British Journal of Haematology (15 papers)Annals of Oncology (8 papers)Cancer (7 papers)
- Partner nations
- United StatesFranceItaly
In The Last Decade
André Goy
324 papers receiving 10.3k citations
André Goy's Hit Papers
Peers
Comparison fields: 5 of 155
- Pathology and Forensic Medicine 5.9k
- Genetics 2.6k
- Oncology 4.4k
- Hematology 1.3k
- Dermatology 663
Countries citing papers authored by André Goy
This map shows the geographic impact of André Goy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Goy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Goy more than expected).
Fields of papers citing papers by André Goy
This network shows the impact of papers produced by André Goy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Goy. The network helps show where André Goy may publish in the future.
Co-authors
The 25 scholars most cited alongside André Goy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 343 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Multicenter Phase II Study of Bortezomib in Patients With Relapsed or Refractory Mantle Cell Lymphoma Hit paper breakdown → | 2006 | 575 |
| 2 | Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study Hit paper breakdown → | 2011 | 454 |
| 3 | 2004 | 436 | |
| 4 | 2005 | 400 | |
| 5 | 2001 | 328 | |
| 6 | 1995 | 294 | |
| 7 | 2015 | 286 | |
| 8 | 2013 | 278 | |
| 9 | 2020 | 264 | |
| 10 | 2008 | 258 | |
| 11 | 1999 | 245 | |
| 12 | 2011 | 226 | |
| 13 | 2004 | 204 | |
| 14 | 2003 | 180 | |
| 15 | 2010 | 175 | |
| 16 | 2016 | 150 | |
| 17 | 2011 | 141 | |
| 18 | 2003 | 130 | |
| 19 | 2004 | 129 | |
| 20 | 2015 | 126 |
About André Goy
André Goy is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Molecular Biology and Hematology, having authored 343 papers that have together received 10.6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (208 papers), Chronic Lymphocytic Leukemia Research (124 papers), CAR-T cell therapy research (53 papers), Viral-associated cancers and disorders (37 papers), Multiple Myeloma Research and Treatments (33 papers), Cutaneous lymphoproliferative disorders research (24 papers), Ubiquitin and proteasome pathways (19 papers) and Monoclonal and Polyclonal Antibodies Research (19 papers). The work is most often cited by research in Pathology and Forensic Medicine (5.9k citations), Genetics (2.6k citations), Oncology (4.4k citations), Hematology (1.3k citations) and Dermatology (663 citations). André Goy has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Barbara Pro, K. Stephen Suh, Peter McLaughlin, Jorge Romaguera, Luis Fayad, Anas Younes, Owen A. O’Connor, Brad S. Kahl, Andrew L. Pecora and Felipe Samaniego. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, Annals of Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.